ARS Pharmaceuticals (SPRY) EBITDA Margin (QoQ) (2022 - 2026)
ARS Pharmaceuticals (SPRY) EBITDA Margin (QoQ) (2022 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - |
| 10 | ARS Pharmaceuticals | 595.78 Mn | 394.81 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -11,755.00 |
| Dec 31, 2025 | 1,603.00 |
| Sep 30, 2025 | 13,928.00 |
| Jun 30, 2025 | 16,334.00 |
| Mar 31, 2025 | -52,080.00 |
| Dec 31, 2024 | 110,616.00 |
| Sep 30, 2024 | 201,636.00 |
| Jun 30, 2023 | -11.25 Mn |
| Sep 30, 2022 | -214,070.00 |
| Jun 30, 2022 | -29,650.00 |